Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Phosphorothioate

Phosphoric Acid and Phosphorothioic Acid Anhydrides. The aUphatic organophosphoms esters originally developed by Schrader (27) are extremely toxic to mammals and are largely of historic interest. Tetraethyl pyrophosphate [107-49-3] (40) (bp 104—110°C at 10.7 Pa, d 1.185, vp 6.1 mPa at 30°C) is miscible with water and hydrolyzes very rapidly with a half-life of 6.8 h at 25°C. The rat LD qS ate 1.1 (oral) and 2.4 (dermal) mg/kg. [Pg.279]

Aliphatic Phosphorothioate Esters. Many of the eady developments of OP insecticides were simple esters of phosphorothioic acid, (H0)2P(0)SH, and phosphorodithioic acid, (HO)2P(S)SH. [Pg.279]

The rat LD qS are 13, 3.6 (oral) and 21, 6.8 (dermal) mg/kg. Parathion is resistant to aqueous hydrolysis, but is hydroly2ed by alkah to form the noninsecticidal diethjlphosphorothioic acid and -nitrophenol. The time required for 50% hydrolysis is 120 d ia a saturated aqueous solution, or 8 h ia a solution of lime water. At temperatures above 130°C, parathion slowly isomerizes to 0,%diethyl 0-(4-nitrophenyl) phosphorothioate [597-88-6] which is much less stable and less effective as an insecticide. Parathion is readily reduced, eg, by bacillus subtilis ia polluted water and ia the mammalian mmen to nontoxic 0,0-diethyl 0-(4-aminophenyl) phosphorothioate, and is oxidized with difficulty to the highly toxic paraoxon [511-45-5] diethyl 4-nitrophenyl phosphate d 1.268, soluble ia water to 2.4 mg/L), rat oral LD q 1.2 mg/kg. [Pg.282]

The hazards of human poisoning by the parathions have stimulated the development of safer analogues. Two chlorinated derivatives have gready reduced mammalian toxicides. Dicapthon [2463-84-5], 0,0-dimethyl 0-(2-chloro-4-nitrophenyl) phosphorothioate (63) (mp 53°C), has rat LD qS of 400, 330 (oral) and 790, 1250 (dermal) mg/kg. Chlorthion [500-20-8], 0,0-dimethyl 0-(3-chloro-4-nitrophenyl) phosphorothioate (64) (mp 21°C, <71.437), has rat LD qS of 890, 980 (oral) and 4500, 4100 (dermal) mg/kg. These compounds have been used as household insecticides. [Pg.282]

The reactivity of the individual O—P insecticides is determined by the magnitude of the electrophilic character of the phosphoms atom, the strength of the bond P—X, and the steric effects of the substituents. The electrophilic nature of the central P atom is determined by the relative positions of the shared electron pairs, between atoms bonded to phosphoms, and is a function of the relative electronegativities of the two atoms in each bond (P, 2.1 O, 3.5 S, 2.5 N, 3.0 and C, 2.5). Therefore, it is clear that in phosphate esters (P=0) the phosphoms is much more electrophilic and these are more reactive than phosphorothioate esters (P=S). The latter generally are so stable as to be relatively unreactive with AChE. They owe their biological activity to m vivo oxidation by a microsomal oxidase, a reaction that takes place in insect gut and fat body tissues and in the mammalian Hver. A typical example is the oxidation of parathion (61) to paraoxon [311-45-5] (110). [Pg.289]

Phosphorothioates. All three synthetic approaches appHcable to unmodified oligonucleotides can be adapted for synthesis of phosphorothioates (11) (33,46). If all of the phosphodiester linkages in an oligonucleotide are to be replaced with phosphorothioates, the ff-phosphonate method for coupling, followed by oxidation with Sg in carbon disulfide and triethylamine in the final step, is the most straightforward method. [Pg.262]

Chirahty at the phosphoms is an unavoidable problem in all phosphorothioate syntheses. The phosphoramidite method produces a mixture of both the and the diastereomers having a small excess of the isomer (53). Although some progress has been made in the chiral synthesis of dinucleoside phosphorothioates, low yields have limited the utility of these approaches. The chiral center may be eliminated by replacing the other, nonbridging oxygen with sulfur. Avoidance of the chirahty problem is one reason for the interest in phosphorodithioates. [Pg.262]

Phosphorothioates generally protect normal tissues more than tumors. Tumor protection reported in some animal studies can pardy be explained by physiological effects of the particular dmgs, which are specific to rodents (4). WR-2721 does not appear to protect human and most animal tumors, apparentiy because of the low availabiUty of the dmg to tumor cells (4). Many tumors appear to have a reduced capillary density (44), which may mean that these tumors have altered levels of alkaline phosphatase, the enzyme that converts WR-2721 to WR-1065. A reduced abiUty of thiols to protect the hypoxic cells characteristic of many tumors may also contribute to their selectivity for normal tissues. The observation that WR-1065 protects cultured normal human fibroblasts, but not fibrosarcoma tumor cells, suggests that additional factors may contribute to the selectivity of radioprotection by WR-2721 m vivo (18). [Pg.489]

Diethyl 0-(3-methyl-5-pyrazolyl) phosphate (722) and 0,0-diethyl 0-(3-methyl-5-pyrazolyl) phosphorothioate (723) were prepared in 1956 by Geigy and they act, as do all organophosphates in both insects and mammals, by irreversible inhibition of acetylcholinesterase in the cholinergic synapses. Interaction of acetylcholine with the postsyn-aptic receptor is therefore greatly potentiated. 0-Ethyl-5-n-propyl-0-(l-substituted pyrazol-4-yl)(thiono)thiolphosphoric acid esters have been patented as pesticides (82USP4315008). [Pg.297]

Phosphorothioic acid, o, o-dlethyl-o- 4-nitrophenyl) ester) Pentachlorophenol (PCP)... [Pg.62]

Phosphorothioate 0,0-DiethylO-2-Isopropyl-4-Methyl-6-Pyrimidyl Thiophosphate Diethyl 2-Isopropyl-4-Methyl 6-Pyrimidyl Thionophosphate Alpha-Tox Saralex Spectracide Cherrucal Formula C]2H2iNj03PS. [Pg.109]

These groups, along with a number of other trialkylsilylethyl derivatives, were examined for protection of phosphorothioates. Only the phenyl-substituted silyl derivative was useful, because simple trialkylsilyl derivatives were prone to acid-catalyzed thiono-thiolo rearrangement. Other trialkylsilylethyl derivatives also suffer from inherent instability upon storage,but the trimethylsilylethyl group has been used successfully in the synthesis of the very sensitive agrocin 84 and for intemucleotide phosphate protection with the phosphoramidite approach. [Pg.676]

Na, ammonia. These conditions also remove cyanoethyl- and benzyl-protective groups. Phosphorothioates are similarly deprotected. [Pg.681]

Cleavage of an 5-2-nitrobenzyl phosphorothioate is achieved with thiophen-... [Pg.685]

From a phosphorothioate TFMSA, m-cresol, thiophenol, TFA. These conditions minimized the migration of the benzyl group to the thione. ... [Pg.685]


See other pages where Phosphorothioate is mentioned: [Pg.312]    [Pg.312]    [Pg.279]    [Pg.280]    [Pg.281]    [Pg.282]    [Pg.282]    [Pg.282]    [Pg.283]    [Pg.283]    [Pg.283]    [Pg.283]    [Pg.285]    [Pg.285]    [Pg.286]    [Pg.286]    [Pg.286]    [Pg.287]    [Pg.287]    [Pg.262]    [Pg.262]    [Pg.262]    [Pg.263]    [Pg.487]    [Pg.487]    [Pg.487]    [Pg.488]    [Pg.489]    [Pg.489]    [Pg.489]    [Pg.489]    [Pg.121]    [Pg.772]    [Pg.340]    [Pg.340]    [Pg.669]   
See also in sourсe #XX -- [ Pg.105 ]

See also in sourсe #XX -- [ Pg.358 ]

See also in sourсe #XX -- [ Pg.1615 ]

See also in sourсe #XX -- [ Pg.51 , Pg.129 , Pg.168 ]

See also in sourсe #XX -- [ Pg.199 , Pg.200 ]

See also in sourсe #XX -- [ Pg.368 , Pg.382 , Pg.390 ]

See also in sourсe #XX -- [ Pg.275 ]

See also in sourсe #XX -- [ Pg.33 ]




SEARCH



0,0-Diethyl 0- phosphorothioate toxicity

0,0-Diethyl 0-[ -4-pyrimidinyl phosphorothioate

0,0-Diethyl 0-[4- phenyl phosphorothioate

0,0-Diethyl-0- phosphorothioate

0,0-dimethyl-0- phosphorothioate

Antisense drugs phosphorothioates

Antisense oligonucleotides phosphorothioate-based

Clinical trials phosphorothioate oligonucleotides

Dialkyl-dialkylaminoethyl phosphorothioates

Diastereoselective synthesis of phosphorothioate

Diethyl 5-2-diethylaminoethyl phosphorothioate

Diethyl phosphorothioic acid

Dinucleotide phosphorothioate triester

Dithymidine phosphorothioate

Glycosyl phosphorothioates

Nuclease phosphorothioates

Nucleoside phosphorothioates

Nucleoside phosphorothioates stereospecific

Nucleoside phosphorothioates synthesis

Nucleosides, phosphorothioate

Nucleosides, phosphorothioate stereospecific synthesis

O-p-Nitrophenyl phosphorothioate

Oligo phosphorothioate

Oligodeoxynucleotides phosphorothioated

Oligonucleoside phosphorothioates

Oligonucleoside phosphorothioates, syntheses

Oligonucleotide therapeutics Phosphorothioate oligonucleotides

Oligonucleotide therapeutics drugs Phosphorothioate

Oligonucleotides phosphorothioate

Organophosphates phosphorothioates

P-nitrophenyl phosphorothioate

Pharmacokinetics phosphorothioates

Phosphorothioate (Thiophosphate) Esters

Phosphorothioate analogues

Phosphorothioate and

Phosphorothioate anion

Phosphorothioate antisense oligonucleotides

Phosphorothioate antisense therapies

Phosphorothioate deoxynucleotides

Phosphorothioate ester

Phosphorothioate group

Phosphorothioate ion

Phosphorothioate links

Phosphorothioate monoester

Phosphorothioate monoesters, synthesis

Phosphorothioate nucleotides

Phosphorothioate oligodeoxynucleotides

Phosphorothioate oligonucleotide

Phosphorothioate oligonucleotide antisense

Phosphorothioate oligonucleotide synthesis

Phosphorothioate oligonucleotides hybridization

Phosphorothioate oligonucleotides nuclease stability

Phosphorothioate oligonucleotides pharmacokinetic properties

Phosphorothioate oligonucleotides pharmacokinetics

Phosphorothioate oligonucleotides protein interactions

Phosphorothioate oligonucleotides toxicology

Phosphorothioate phosphotransferases in study

Phosphorothioate, synthesis

Phosphorothioate-based oligos

Phosphorothioates

Phosphorothioates

Phosphorothioates and phosphorodithioates containing alkylthioalkyl or arylthioalkyl groups

Phosphorothioates as substrates

Phosphorothioates chiral synthesis

Phosphorothioates diastereoselective synthesis

Phosphorothioates hydrolysis

Phosphorothioates isomer separations

Phosphorothioates nucleoside 2 ,3 -cyclic

Phosphorothioates oxidative cleavage

Phosphorothioates phosphorylation

Phosphorothioates, chiral

Phosphorothioates, stereospecific

Phosphorothioates, stereospecific synthesis

Phosphorothioic acid

Phosphorothioic acid 0,0’-diethyl ester

Phosphorothioic acid, 0,0-dimethyl

Phosphorothioic acid, 0,0-dimethyl ester

Phosphorothioic triamide, hexamethyl

Proteins interactions with phosphorothioate oligonucleotides

RNA phosphorothioate

Sodium phosphorothioate

Solution phase synthesis phosphorothioates

Stereospecific synthesis nucleoside phosphorothioates

Substituted dialkyl-phenyl phosphates and phosphorothioates

Trialkyl phosphorothioates

Trisodium phosphorothioate

Uridine 2 ,3 -phosphorothioate

Uridine 2 .3 -cyclic phosphorothioate

© 2024 chempedia.info